Your browser doesn't support javascript.
loading
[Short-term Outcome of T1bN0M0 Papillary Thyroid Cancer after Ultrasonography-guided Radiofrequency Ablation].
Xiao, Jing; Lan, Yu; Yan, Lin; Zhang, Ming Bo; Zhang, Yan; Xie, Fang; Song, Qing; Luo, Yu Kun; Tang, Jie.
Affiliation
  • Xiao J; School of Medicine,Nankai University,Tianjin 300071,China.
  • Lan Y; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Yan L; School of Medicine,Nankai University,Tianjin 300071,China.
  • Zhang MB; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Zhang Y; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Xie F; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Song Q; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Luo YK; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
  • Tang J; Department of Ultrasound,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 42(6): 771-775, 2020 Dec 30.
Article in Zh | MEDLINE | ID: mdl-33423724
Objective To investigate the short-term outcome of T1bN0M0 papillary thyroid cancer after ultrasonography-guided radiofrequency ablation(RFA). Methods Eighty-nine patients with T1bN0M0 papillary thyroid cancer who were treated with ultrasonography-guided RFA in our center from April 2014 to January 2019 were retrospectively analyzed.Trans-isthmus approach and moving shot technique were used during the RFA procedure.Ultrasonography and contrast-enhanced ultrasonography were performed before ablation,and immediately,1,3,6 and 12 months after ablation and then every 6 months thereafter. Results RFA was performed in 89 cases of papillary thyroid cancer,and no major complications were observed during the RFA.The mean follow-up was(18.8±7.3)months.The ablation zones decreased gradually during follow-up,and 38 ablation zones(42.7%)completely disappeared.The volume reduction rate was(99.2±2.3)% 30 months after ablation.During follow-up,2 patients(2.2%)developed tumor recurrence and 1 patient(1.1%)developed cervical lymph node metastasis. Conclusion Ultrasonography-guided RFA may be a safe and effective method for patients with T1bN0M0 papillary thyroid cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Catheter Ablation / Thyroid Cancer, Papillary / Radiofrequency Ablation Type of study: Diagnostic_studies / Observational_studies Limits: Humans Language: Zh Journal: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Year: 2020 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Catheter Ablation / Thyroid Cancer, Papillary / Radiofrequency Ablation Type of study: Diagnostic_studies / Observational_studies Limits: Humans Language: Zh Journal: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Year: 2020 Type: Article Affiliation country: China